{"id":"W2074985728","doi":"10.1503/cmaj.090917","title":"The Enhancing Secondary Prevention in Coronary Artery Disease trial","year":2009,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; University of Calgary; University of Alberta; Foothills Medical Centre; University of Ottawa; Royal Alexandra Hospital","funders":"Eli Lilly Canada; Fondation pour la Recherche Médicale; W. Garfield Weston Foundation; Boston Scientific Corporation; Pfizer; Heart and Stroke Foundation of Canada; Pfizer Canada; Sanofi; Alberta Heritage Foundation for Medical Research; University of Alberta; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Statin; Coronary artery disease; Guideline; Randomized controlled trial; Odds ratio; Internal medicine; Cardiac catheterization; Clinical endpoint; Physical therapy; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002883097,0.0005839502,0.001359703,0.0002314321,0.0002338473,0.0006571386,0.0003623748,0.001032402,0.00396532],"category_scores_gemma":[0.004873942,0.0002328879,0.001254286,0.0002564022,0.0004656692,0.0004559935,0.0005073108,0.001721424,0.0003433378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003492835,"about_ca_system_score_gemma":0.0007637132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005009863,"about_ca_topic_score_gemma":0.0007737211,"domain_scores_codex":[0.9981311,0.001415198,0.0001050218,0.0001601201,0.00009827472,0.00009029245],"domain_scores_gemma":[0.9976419,0.001056945,0.0007222659,0.0001509217,0.00008305645,0.0003450325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9070465,0.00865013,0.007031748,0.004804417,0.00473194,0.00009515396,0.0001564309,0.0009548882,0.002104368,0.0008220667,0.00470292,0.05889948],"study_design_scores_gemma":[0.9145288,0.05652859,0.01960343,0.00082546,0.003636615,0.0000695746,0.0000545545,0.0009860354,0.0005436535,0.0006521005,0.002554776,0.00001636457],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742996,0.01458308,0.0007749793,0.002563607,0.0003917222,0.00188015,0.001082651,0.00008122119,0.004343077],"genre_scores_gemma":[0.9846751,0.004964957,0.002495643,0.001641411,0.0006641335,0.00294643,0.0008302322,0.00001024253,0.001771713],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00396532,"threshold_uncertainty_score":0.0152474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007108351548822551,"score_gpt":0.2492820588600071,"score_spread":0.2421737073111845,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}